← Leaderboards
John A T Young
University Of Wisconsin Madison
$16,502,154
Attributed
$17,685,923
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–16$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$33,986,193 · 10
By mechanism
P01$19,912,571 · 3
R01$11,015,565 · 5
U19$3,058,057 · 1
P30$0 · 1
Top collaborators
- Marianne Manchester5 shared
Others in their field
Top investigators on “Receptor Binding”
- Barton F Haynes · Duke University$185,264,749
- James C. Paulson · Scripps Research Institute$95,448,398
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$46,554,883
- Anthony O Caggiano · Cognition Therapeutics, Inc.$43,047,809
- Norbert E Kaminski · Michigan State University$39,404,844
- Leonidas A Stamatatos · Fred Hutchinson Cancer Center$39,383,866
Research focus
Receptor BindingBaseInfectionProgramsFutureProteinsInsightHiv-1Antiviral AgentsVirus ReceptorsVaccinesVirusViralPathogenVirus ReplicationResearch PersonnelImmune ResponseVirus DiseasesGene ExpressionChimeric ProteinsTissue /Cell CultureMolecular CloningAvian Leukosis VirusCells
Grant awards (49)
Genomics Core$1,022,088
U19 · FY2016 · AI · contact PI
Genomics Core$969,998
U19 · FY2015 · AI · contact PI
Impact of innate responses upon HIV replication$573,080
P01 · FY2014 · AI · contact PI
Administrative and Data Managment Core$164,361
P01 · FY2014 · AI · contact PI
Global innate immune responses to HIV-1 infection$3,860,288
P01 · FY2013 · AI · contact PI
Genomics Core$1,065,971
U19 · FY2013 · AI · contact PI
Impact of innate responses upon HIV replication$435,615
P01 · FY2013 · AI · contact PI
Administrative and Data Managment Core$184,921
P01 · FY2013 · AI · contact PI
Global innate immune responses to HIV-1 infection$4,024,406
P01 · FY2012 · AI · contact PI
Receptor Decoy Inhibitor of Anthrax Toxin$464,225
R01 · FY2012 · AI · contact PI
Impact of innate responses upon HIV replication$457,815
P01 · FY2012 · AI · contact PI
Administrative and Data Managment Core$194,350
P01 · FY2012 · AI · contact PI
Global innate immune responses to HIV-1 infection$86,520
P01 · FY2012 · AI · contact PI
Global innate immune responses to HIV-1 infection$4,074,664
P01 · FY2011 · AI · contact PI
Impact of innate responses upon HIV replication$471,760
P01 · FY2011 · AI · contact PI
Receptor Decoy Inhibitor of Anthrax Toxin$464,225
R01 · FY2011 · AI · contact PI
Cellular factors in gammaretrovirus replication$427,389
R01 · FY2011 · AI · contact PI
Administrative and Data Managment Core$287,122
P01 · FY2011 · AI · contact PI
Global innate immune responses to HIV-1 infection$4,254,392
P01 · FY2010 · AI · contact PI
Impact of innate responses upon HIV replication$489,017
P01 · FY2010 · AI · contact PI
Receptor Decoy Inhibitor of Anthrax Toxin$468,914
R01 · FY2010 · AI · contact PI
Cellular factors in gammaretrovirus replication$431,707
R01 · FY2010 · AI · contact PI
Administrative and Data Managment Core$354,260
P01 · FY2010 · AI · contact PI
Receptor Decoy Inhibitor of Anthrax Toxin$473,650
R01 · FY2009 · AI · contact PI
Cellular factors in gammaretrovirus replication$436,067
R01 · FY2009 · AI · contact PI
Anthrax Toxin Entry into Cells$582,062
R01 · FY2008 · AI · contact PI
Receptor Decoy Inhibitor of Anthrax Toxin$496,525
R01 · FY2008 · AI · contact PI
Cellular factors in gammaretrovirus replication$436,067
R01 · FY2008 · AI · contact PI
Anthrax Toxin Entry into Cells$579,532
R01 · FY2007 · AI · contact PI
Cellular factors in gammaretrovirus replication$467,388
R01 · FY2007 · AI · contact PI
Anthrax Toxin Entry into Cells$583,036
R01 · FY2006 · AI · contact PI
Anthrax Toxin Entry into Cells$581,627
R01 · FY2005 · AI
Anthrax Toxin Entry into Cells$586,123
R01 · FY2004 · AI
CHARACTERIZING THE MECHANISMS OF ALSV ENTRY INTO CELLS$293,265
R01 · FY2004 · CA
STRATEGIES TO INHIBIT CELLULAR UPTAKE OF ANTHRAX TOXIN$449,673
R01 · FY2003 · AI
CHARACTERIZING THE MECHANISMS OF ALSV ENTRY INTO CELLS$143,368
R01 · FY2003 · CA
MECHANISMS OF CELL KILLING INDUCED BY RETROVIRUSES$129,550
R01 · FY2003 · CA
MECHANISMS OF CELL KILLING INDUCED BY RETROVIRUSES$111,039
R01 · FY2003 · CA
CHARACTERIZING THE MECHANISMS OF ALSV ENTRY INTO CELLS$83,432
R01 · FY2003 · CA
STRATEGIES TO INHIBIT CELLULAR UPTAKE OF ANTHRAX TOXIN$346,383
R01 · FY2002 · AI
MECHANISMS OF CELL KILLING INDUCED BY RETROVIRUSES$233,581
R01 · FY2002 · CA
CHARACTERIZING THE MECHANISMS OF ALSV ENTRY INTO CELLS$226,800
R01 · FY2002 · CA
CORE--SCIENTIFIC INSTRUMENT FACILITY$0
P30 · FY2002 · CA
STRATEGIES TO INHIBIT CELLULAR UPTAKE OF ANTHRAX TOXIN$359,538
R01 · FY2001 · AI
CHARACTERIZING THE MECHANISMS OF ALSV ENTRY INTO CELLS$226,800
R01 · FY2001 · CA
MECHANISMS OF CELL KILLING INDUCED BY RETROVIRUSES$226,777
R01 · FY2001 · CA
STRATEGIES TO INHIBIT CELLULAR UPTAKE OF ANTHRAX TOXIN$314,839
R01 · FY2000 · AI
CHARACTERIZING THE MECHANISMS OF ALSV ENTRY INTO CELLS$205,667
R01 · FY2000 · CA
MECHANISMS OF CELL KILLING INDUCED BY RETROVIRUSES$186,316
R01 · FY2000 · CA